R&D Partner Content 5th Supply Chain & Logistics for Cell Therapies Summit Uniting Supply Chain & Clinical Operation Leaders
R&D Partner Content 5th TCR-based Therapies for Solid Tumors Summit Advancing TCR-based Cell Therapies & Bispecific Approaches
R&D Partner Content Biophysics for Drug Discovery Summit Advance Biophysics Technologies & Applications to Measure Molecular & Target Interactions
R&D Partner Content Polymer Chemistry & Formulation in Drug Delivery Design Your Novel Polymers & Maximize Payload Compatibility for Sustained & Controlled Release
R&D Partner Content 5th Gene Therapy Analytical Development Europe Summit return... Develop, Validate and Implement Analytical Tools for Complex Gene Therapies
R&D Partner Content 7th Gene Therapy for Rare Disorders Summit returns to Boston... Accelerating Safe, Effective & Accessible Therapies in Rare Diseases
News ASH: Gilead preps filing for anito-cel on iMMagine-1 data Gilead's Kite unit has showcased three new CAR-T therapies at ASH, headed by multiple myeloma candidate anito-cel, which could launch next year.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
